On June 11th, Gelonhui reported that Mr. He Shi, the company's board secretary, accumulated 93,300 shares of the company through centralized bidding trading on the Shanghai Stock Exchange system as of June 7, 2024, accounting for 0.0212% of the total shares of the company, with a total increase of RMB 1,064,100. The shareholding plan for this increase has been completed.
方盛制药(603998.SH)：董事会秘书何仕累计增持9.33万股公司股份
Hunan Fangsheng Pharmaceutical (603998.SH): the board of directors' secretary He Shi accumulated a shareholding of 93,300 shares of the company's stock.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.